Linked Life Data

9195720

Source:http://linkedlifedata.com/resource/pubmed/id/9195720

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-3
pubmed:dateCreated
1997-8-8
pubmed:abstractText
The efficacy of a 2% moxidectin equine gel at a dosage rate of 0.4 mg kg-1 was evaluated in a controlled trial at Utrecht University. Twelve yearling castrated male Shetland ponies grazed a pasture of 2 ha from May 1994 until housing in November. Six ponies were treated with moxidectin, whereas the others served as non-treated controls. Necropsy was carried out 35 days after treatment. Greater than 99% efficacy of moxidectin was observed on faecal egg output. No effect of moxidectin was observed on mucosal inhibited early cyathostome L3 (EL3) or on the total numbers of mucosal developing stages. However, a 89.6% reduction was observed on large mucosal fourth stage larvae (L4). Moxidectin treatment probably triggered resumption of development of EL3. Moxidectin appeared to be highly effective (95-100%) on lumenal L4 cyathostomes, adult strongylids, Strongylus vulgaris larvae from the arteries, S. edentatus larvae from the abdominal wall and Trichostrongylus axei. Moxidectin had relatively poor efficacy against Gasterophilus intestinalis and had no effect on Anoplocephala perfoliata. No side-effects of moxidectin treatment were observed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0304-4017
pubmed:author
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
165-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Controlled dose confirmation study of a 2% moxidectin equine gel against equine internal parasites in The Netherlands.
pubmed:affiliation
Department of Parasitology and Tropical Veterinary Medicine, Utrecht University, The Netherlands.
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't